Is Daprodustat the Chinese name and drug introduction?
Daprodustat is the Chinese name of Daprodustat. This is an oral small molecule drug that belongs to the HIF-PHI class (hypoxia-inducible factor prolyl hydroxylase inhibitor). It is mainly used to treat renal anemia, especially for patients with anemia caused by chronic kidney disease (CKD). Different from the traditional use of injectable erythropoietin drugs, daprostat promotes the secretion of endogenous erythropoietin (EPO) by simulating a hypoxic state, thereby stimulating red blood cell production.
Daprostat was developed by Japan's Daiichi Sankyo (Daiichi Sankyo) and subsequently promoted in cooperation with the British GlaxoSmithKline (GSK). Currently, the drug has been marketed in many countries and regions such as Japan, the United States, and the European Union, and is used to treat anemia patients with CKD who are undergoing dialysis or not undergoing dialysis. Compared with traditional therapies, dapostat provides a new option for oral administration, simplifying the treatment process and improving patient compliance.

The drug's mechanism of action is to inhibit prolyl hydroxylase in the HIF pathway, promote the stable expression of HIF-α, and then activate a variety of genes related to hematopoiesis and iron metabolism. This mechanism can not only stimulate the production of EPO, but also improve the iron metabolism environment and reduce dependence on exogenous iron. Therefore, daprostat not only improved the anemia correction rate, but also demonstrated certain safety and tolerability in clinical studies.
Up to now, daprostat has not been fully launched in mainland China, but with the promotion of similar HIF-PHI drugs such as roxadustat (Roxadustat) in the Chinese market, daprostat is expected to enter the domestic market in the future and provide new treatment options for more patients with renal anemia. Daprostat is a promising new anemia treatment for patients who cannot tolerate injections or who wish to take oral treatment.
Reference materials:https://en.wikipedia.org/wiki/Daprodustat
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)